- Home
- EKSO vs PMCB Comparison
EKSO vs PMCB Comparison
Compare EKSO & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EKSO
- PMCB
- Stock Information
- Founded
- EKSO 2005
- PMCB 1996
- Country
- EKSO United States
- PMCB United States
- Employees
- EKSO N/A
- PMCB N/A
- Industry
- EKSO Medical/Dental Instruments
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EKSO Health Care
- PMCB Health Care
- Exchange
- EKSO Nasdaq
- PMCB Nasdaq
- Market Cap
- EKSO 14.9M
- PMCB 13.9M
- IPO Year
- EKSO N/A
- PMCB N/A
- Fundamental
- Price
- EKSO $0.70
- PMCB $1.65
- Analyst Decision
- EKSO Strong Buy
- PMCB
- Analyst Count
- EKSO 2
- PMCB 0
- Target Price
- EKSO $5.50
- PMCB N/A
- AVG Volume (30 Days)
- EKSO 132.0K
- PMCB 15.6K
- Earning Date
- EKSO 10-28-2024
- PMCB 12-24-2024
- Dividend Yield
- EKSO N/A
- PMCB N/A
- EPS Growth
- EKSO N/A
- PMCB N/A
- EPS
- EKSO N/A
- PMCB 0.74
- Revenue
- EKSO $17,682,000.00
- PMCB N/A
- Revenue This Year
- EKSO $1.11
- PMCB N/A
- Revenue Next Year
- EKSO $38.63
- PMCB N/A
- P/E Ratio
- EKSO N/A
- PMCB $2.27
- Revenue Growth
- EKSO 4.12
- PMCB N/A
- 52 Week Low
- EKSO $0.50
- PMCB $1.39
- 52 Week High
- EKSO $3.13
- PMCB $2.58
- Technical
- Relative Strength Index (RSI)
- EKSO 52.12
- PMCB 45.07
- Support Level
- EKSO $0.50
- PMCB $1.61
- Resistance Level
- EKSO $0.75
- PMCB $1.81
- Average True Range (ATR)
- EKSO 0.06
- PMCB 0.11
- MACD
- EKSO 0.02
- PMCB 0.00
- Stochastic Oscillator
- EKSO 94.36
- PMCB 43.64
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.